Latest filing published 13 Jul 2026 for Suzhou Ribo Life Science Co., Ltd. - B - H Shares, €40k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Gan Liming: trading record in brief
Gan Liming appears in our data through filings on Suzhou Ribo Life Science Co., Ltd. - B - H Shares shares, published by HKEX. Over a trading history stretching from 30 June 2026 to 9 July 2026, the count stands at 3 filings.
No open-market sale appears; the market trades are 3 purchases worth €112k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The median purchase comes to €37k.
The newest entry dates from 13 July 2026: an open-market purchase of €40k, in Suzhou Ribo Life Science Co., Ltd. - B - H Shares. Filings reach the HKEX feed a median of 4 days after the trade. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Companies and markets linked to Gan Liming
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,800 shares@ HK$52.6859ShareXHKGHKEX:DA20260713E00422Canonical exit: 7 Oct 2026 (T+90)
- 6,000 shares@ HK$52.0048.5% of flowShareXHKGHKEX:DA20260706E00436Canonical exit: 1 Oct 2026 (T+90)
- 7,200 shares@ HK$45.966751.5% of flowShareXHKGHKEX:DA20260706E00432Canonical exit: 28 Sept 2026 (T+90)
3 of 3 declarations